Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Filament Health Corp.
Filament Health Announces First Dosing in Groundbreaking FDA-Approved Psilocin Clinical Trial
July 07, 2022
From
Filament Health Corp.
Via
Business Wire
Tickers
FLHLF
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.